Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Overview

Journal J Vis Exp

Specialties Biology
General Medicine

Date 2015 Dec 10

PMID 26649751

Citations 26

Authors

Li Wang

Ziqing Liu

Chaoying Yin

Yang Zhou

Jiandong Liu

Li Qian

Affiliations

Soon will be listed here.

Abstract

Direct conversion of cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) holds great potential for regenerative medicine by offering alternative strategies for treatment of heart disease. This conversion has been achieved by forced expression of defined factors such as Gata4 (G), Mef2c (M) and Tbx5 (T). Traditionally, iCMs are generated by a cocktail of viruses expressing these individual factors. However, reprogramming efficiency is relatively low and most of the in vitro G,M,T-transduced fibroblasts do not become fully reprogrammed, making it difficult to study the reprogramming mechanisms. We recently have shown that the stoichiometry of G,M,T is crucial for efficient iCM reprogramming. An optimal stoichiometry of G,M,T with relative high level of M and low levels of G and T achieved by using our polycistronic MGT vector (hereafter referred to as MGT) significantly increased reprogramming efficiency and improved iCM quality in vitro. Here we provide a detailed description of the methodology used to generate iCMs with MGT construct from cardiac fibroblasts. Isolation of cardiac fibroblasts, generation of virus for reprogramming and evaluation of the reprogramming process are also included to provide a platform for efficient and reproducible generation of iCMs.

Citing Articles

Direct Cardiac Reprogramming in the Age of Computational Biology.

Ambroise R, Takasugi P, Liu J, Qian L J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330331 PMC: 11432431. DOI: 10.3390/jcdd11090273.

Direct conversion of cardiac fibroblasts into endothelial-like cells using Sox17 and Erg.

Farber G, Dong Y, Wang Q, Rathod M, Wang H, Dixit M Nat Commun. 2024; 15(1):4170.

PMID: 38755186 PMC: 11098819. DOI: 10.1038/s41467-024-48354-6.

14-3-3 binding motif phosphorylation disrupts Hdac4-organized condensates to stimulate cardiac reprogramming.

Liu L, Lei I, Tian S, Gao W, Guo Y, Li Z Cell Rep. 2024; 43(4):114054.

PMID: 38578832 PMC: 11081035. DOI: 10.1016/j.celrep.2024.114054.

Cardiomyocyte-fibroblast interaction regulates ferroptosis and fibrosis after myocardial injury.

Mohr M, Li S, Trouten A, Stairley R, Roddy P, Liu C iScience. 2024; 27(3):109219.

PMID: 38469561 PMC: 10926204. DOI: 10.1016/j.isci.2024.109219.

Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblasts.

Tao Y, Yang Y, Yang Z, Wang L, Wang S, Zhao Y iScience. 2023; 26(12):108466.

PMID: 38077137 PMC: 10709133. DOI: 10.1016/j.isci.2023.108466.

References

Muraoka N, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Isomi M . MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J. 2014; 33(14):1565-81. PMC: 4198052. DOI: 10.15252/embj.201387605. View

Srivastava D, Ieda M, Fu J, Qian L . Cardiac repair with thymosin β4 and cardiac reprogramming factors. Ann N Y Acad Sci. 2012; 1270:66-72. DOI: 10.1111/j.1749-6632.2012.06696.x. View

Srivastava D, Ieda M . Critical factors for cardiac reprogramming. Circ Res. 2012; 111(1):5-8. PMC: 3404813. DOI: 10.1161/CIRCRESAHA.112.271452. View

Christoforou N, Chellappan M, Adler A, Kirkton R, Wu T, Addis R . Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One. 2013; 8(5):e63577. PMC: 3660533. DOI: 10.1371/journal.pone.0063577. View

Nam Y, Song K, Luo X, Daniel E, Lambeth K, West K . Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A. 2013; 110(14):5588-93. PMC: 3619357. DOI: 10.1073/pnas.1301019110. View

Nam Y, Lubczyk C, Bhakta M, Zang T, Fernandez-Perez A, McAnally J . Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development. 2014; 141(22):4267-78. PMC: 4302916. DOI: 10.1242/dev.114025. View

Senyo S, Steinhauser M, Pizzimenti C, Yang V, Cai L, Wang M . Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2012; 493(7432):433-6. PMC: 3548046. DOI: 10.1038/nature11682. View

Inagawa K, Miyamoto K, Yamakawa H, Muraoka N, Sadahiro T, Umei T . Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012; 111(9):1147-56. DOI: 10.1161/CIRCRESAHA.112.271148. View

Chen J, Krane M, Deutsch M, Wang L, Rav-Acha M, Gregoire S . Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res. 2012; 111(1):50-5. PMC: 3390172. DOI: 10.1161/CIRCRESAHA.112.270264. View

10.

Choi W, Poss K . Cardiac regeneration. Curr Top Dev Biol. 2012; 100:319-44. PMC: 3342383. DOI: 10.1016/B978-0-12-387786-4.00010-5. View

11.

Ieda M, Fu J, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau B . Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142(3):375-86. PMC: 2919844. DOI: 10.1016/j.cell.2010.07.002. View

12.

Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y . Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res. 2014; 116(2):237-44. PMC: 4299697. DOI: 10.1161/CIRCRESAHA.116.305547. View

13.

Protze S, Khattak S, Poulet C, Lindemann D, Tanaka E, Ravens U . A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol. 2012; 53(3):323-32. DOI: 10.1016/j.yjmcc.2012.04.010. View

14.

Souders C, Bowers S, Baudino T . Cardiac fibroblast: the renaissance cell. Circ Res. 2009; 105(12):1164-76. PMC: 3345531. DOI: 10.1161/CIRCRESAHA.109.209809. View

15.

Jayawardena T, Egemnazarov B, Finch E, Zhang L, Payne J, Pandya K . MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012; 110(11):1465-73. PMC: 3380624. DOI: 10.1161/CIRCRESAHA.112.269035. View

16.

Wang H, Cao N, Spencer C, Nie B, Ma T, Xu T . Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep. 2014; 6(5):951-60. PMC: 4004339. DOI: 10.1016/j.celrep.2014.01.038. View

17.

Whelan R, Kaplinskiy V, Kitsis R . Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010; 72:19-44. DOI: 10.1146/annurev.physiol.010908.163111. View

18.

Mathison M, Gersch R, Nasser A, Lilo S, Korman M, Fourman M . In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2013; 1(6):e005652. PMC: 3540681. DOI: 10.1161/JAHA.112.005652. View

19.

Moore-Morris T, Guimaraes-Camboa N, Banerjee I, Zambon A, Kisseleva T, Velayoudon A . Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest. 2014; 124(7):2921-34. PMC: 4071409. DOI: 10.1172/JCI74783. View

20.

Hosoda T, DAmario D, Cabral-da-Silva M, Zheng H, Padin-Iruegas M, Ogorek B . Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A. 2009; 106(40):17169-74. PMC: 2761310. DOI: 10.1073/pnas.0903089106. View